About AAT Bioquest
AAT Bioquest is a company based in Sunnyvale (United States) founded in 2006. The company has 31 employees. AAT Bioquest offers products and services including Gelite™ Safe DNA Gel Stain, Poly-HRP/PSA™ Detection System, Cell Navigator®, and iFluor® Secondary Antibody Conjugates. AAT Bioquest operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
- Headquarter Sunnyvale, United States
- Employees 31
- SectorsHealthcare
- Website category Science and Education · Biology
- Email••••••••
- Phone•••• ••••
- Website aatbio.com
- Social LinkedIn X Facebook
- Legal Name Aat Bioquest
- Latest Funding Round$100K (USD), Grant
Jul 2008
- Investors
- Employee Count31
Products & Services of AAT Bioquest
AAT Bioquest offers a comprehensive portfolio of products and services, including Gelite™ Safe DNA Gel Stain, Poly-HRP/PSA™ Detection System, Cell Navigator®, and iFluor® Secondary Antibody Conjugates.
Robust DNA gel stain for safe electrophoresis applications
System for tissue staining using iFluor-PSA™ substrate
Guides for live cell imaging of nucleus and organelles
Conjugates for visualizing cellular structures like tubulin
Funding Insights of AAT Bioquest
- Total Rounds 1
- Last Round Grant — $100,000
- First Round $100,000
(Jul 2008)
- Investors Count 1
All 1 funding rounds of AAT Bioquest with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2008 | $100,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in AAT Bioquest
AAT Bioquest has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for AAT Bioquest
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AAT Bioquest
8 people are tracked at AAT Bioquest (2 in leadership, 6 in team); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
Jack Diwu | President | Leadership |
Qin Zhao | Director Of Biochemistry & Immunology | Leadership |
Lok Neupane | Staff Scientist | Team |
Jianjun He | Staff Scientist | Team |
Sharon Chang | Manager Of Production, Biology | Team |
Joseph Meacham | Marketing And Business Development | Team |
Deven Patel | Staff Scientist | Team |
M.D. Motiur Rahman | Staff Scientist II | Team |
Complete people profiles for AAT Bioquest
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AAT Bioquest
2 dated milestones of AAT Bioquest across 2 years, from founding to its latest funding, stage changes and deals.
- Founded AAT Bioquest is founded.
- Funding First funding round of $100K.
Competitors of AAT Bioquest
AAT Bioquest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | – | 301 | Kits and reagents are developed for life science research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| biochain.com | 1994 | Hayward, United States | $7.34M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| biolamina.com | 2008 | Sundbyberg, Sweden | $18.25M | – | Recombinant laminins are produced for stem cell culture matrices. |
Detailed competitors of AAT Bioquest
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AAT Bioquest
The website of AAT Bioquest (aatbio.com) receives about 285.9K visits a month and ranks #194,530 among all websites worldwide, #12,530 in Biology.
- Monthly visits285.9K
▲ 8.4% vs previous month
- Unique visitors124.8K
per month
- Global rank#194,530
among all websites
- Category rank#12,530
Science and Education · Biology
- Bounce rate52%
- Pages per visit1.7
- Average visit41 sec
- DevicesDesktop 41% · Mobile 59%
Websites whose visitors overlap most with AAT Bioquest. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
promega.com | promega.com | 100% | – | #192,389 | – |
| moleculardevices.com | 91% | 131.7K | #329,224 | View details | |
| anaspec.com | 85% | 30.1K | #1,080,158 | View details | |
enzolifesciences.com | enzolifesciences.com | 85% | – | – | – |
| lubio.ch | 82% | 33.6K | #958,744 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for AAT Bioquest
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to AAT Bioquest
10 companies that operate in the same segment as AAT Bioquest (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AAT Bioquest
AAT Bioquest was founded in 2006 and raised its 1st funding round 2 years after it was founded.
AAT Bioquest is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
AAT Bioquest has 31 employees.
AAT Bioquest is engaged in the development, manufacturing and marketing of bioanalytical research reagents and kits for life sciences research, diagnostic RD and drug discovery industry. The company offers tools and products based on photometric detections including absorption (color), fluorescence and luminescence technologies. Its product portfolio includes Antibodies, Biochemical assays, Building blocks, Cell-based assays, HTS assays, and Labeling probes. In addition, the company offers custom synthesis of colorimetric, fluorescent and luminescent probes, custom development of biochemical, cell-based and diagnostic assays and custom screening of compound libraries against defined targets using the companys validated HTS assays.
AAT Bioquest's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
AAT Bioquest offers Gelite™ Safe DNA Gel Stain, Poly-HRP/PSA™ Detection System, Cell Navigator®, and iFluor® Secondary Antibody Conjugates.
AAT Bioquest has 1 investor. Key investors include HHS.
AAT Bioquest operates through Aat Bioquest.
The website of AAT Bioquest receives about 286 thousand visits a month and ranks #194,530 among all websites worldwide.